Comments on “Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999;112:430-432
摘要篇首:Editors, We would like to congratulate Cao and his colleagues on the extremely good mean survival rate of 19.5 months achieved in 17 patients with non-resectable liver cancer (16 primary and 1 metastatic).1 Because the results of their study sounds so promising, centres having access to glass yttrium-90 (90Y) microspheres may want to try their methods. It is therefore necessary to clarify some of the points mentioned in their report.
更多相关知识
- 浏览120
- 被引0
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文